Results 31 to 40 of about 15,054 (69)

Tumor microenvironment differences between diagnostic and relapsed classic Hodgkin lymphoma revealed by scRNA-seq

open access: yesBlood Advances
: Classical Hodgkin lymphoma (CHL) is characterized by a complex tumor microenvironment (TME) that supports disease progression. Although immune cell recruitment by Hodgkin and Reed-Sternberg (HRS) cells is well documented, the role of nonmalignant B ...
Yifan Yin   +13 more
doaj   +1 more source

Embryonic thermal manipulation improved early immunity in broiler chickens

open access: yesFrontiers in Physiology
Immunity in chickens is age-dependent and develops gradually over time. The initial defense by the host is a crucial mechanism for combating microbial infections. Embryonic thermal manipulation (TM) represents a promising approach for sustainable broiler
Sadid Al Amaz   +5 more
doaj   +1 more source

Notch1 signaling in NOTCH1-mutated mantle cell lymphoma depends on Delta-Like ligand 4 and is a potential target for specific antibody therapy

open access: yesJournal of Experimental & Clinical Cancer Research, 2019
Background NOTCH1 gene mutations in mantle cell lymphoma (MCL) have been described in about 5–10% of cases and are associated with significantly shorter survival rates.
Elisabeth Silkenstedt   +14 more
doaj   +1 more source

A single-cell immune atlas of primary and secondary lymphoid organs in pigs

open access: yesFrontiers in Immunology
Single-cell RNA sequencing (scRNA-seq) has revolutionized understandings of cellular identities and functions due to the ability to study transcriptome-wide gene expression within individual cells.
Jayne E. Wiarda   +7 more
doaj   +1 more source

ILC2s and their immune checkpoints in the antitumor response

open access: yesJournal for ImmunoTherapy of Cancer
Innate lymphoid cells (ILCs) are tissue-resident lymphocytes that patrol mucosal barriers. Among ILC subsets, ILC2s’ involvement in the innate immune response to parasites, in the development of asthma and in the repair of damaged tissues is well known ...
Lorenzo Moretta   +4 more
doaj   +1 more source

Genome-wide discovery of somatic regulatory variants in diffuse large B-cell lymphoma

open access: yesNature Communications, 2018
The driver mutations for the two main molecular subgroups of diffuse large B-cell lymphoma (DLBCL) are poorly defined. Here, an integrative genomics analysis identifies 3′ UTR NFKBIZ mutations within the activated B-cell DLBCL subgroup and small FCGR2B ...
Sarah E. Arthur   +35 more
doaj   +1 more source

Population-wide introduction of dose-adjusted EPOCH-R in high-grade B-cell lymphoma with MYC/BCL2 rearrangements, DLBCL morphology

open access: yesBlood Advances
: High-grade B-cell lymphoma with ''double-hit'' MYC and BCL2 rearrangements (HGBCL-DH-BCL2) is associated with poor outcomes following standard chemoimmunotherapy, prompting dose-intensive regimen use.
Waleed Alduaij   +18 more
doaj   +1 more source

TREATMENT OF HIV-ASSOCIATED BURKITT LYMPHOMA [PDF]

open access: yesEuropean Medical Journal Hematology, 2013
Burkitt lymphoma (BL) is a highly aggressive B-cell malignancy, occurring with increased frequency among patients infected with HIV. For several years, the immunocompromised state of HIV-positive patients was advocated as a sufficient reason to avoid the
Giovanni Donadoni   +2 more
doaj  

Utility of the Central Nervous System International Prognostic Index in patients with primary mediastinal large B-cell lymphoma treated with rituximab-containing chemoimmunotherapy

open access: yesHaematologica
Not available.
Jiayu Yang   +9 more
doaj   +1 more source

Retreatment with R-CHOP–like therapy in patients with late relapse of diffuse large B-cell lymphoma

open access: yesBlood Advances
: Patients with diffuse large B-cell lymphoma (DLBCL) with late relapse (>2 years from diagnosis) may be treated with a second course of R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone)–like therapy particularly if ...
Jean-Nicolas Champagne   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy